Last updated: August 6, 2025
Introduction
China patent CN104822383 pertains to an innovative pharmaceutical invention designed to address specific medical needs. As an integral part of the national intellectual property framework, this patent influences the competitive landscape of drug development, licensing, and commercialization within China and potentially international markets. This report offers a comprehensive examination of the patent’s scope, claims, and the broader patent landscape, providing critical insights for stakeholders, including pharmaceutical companies, patent analysts, and legal professionals.
Overview of Patent CN104822383
CN104822383 was granted by the China National Intellectual Property Administration (CNIPA) and published on April 29, 2015. Its primary focus appears to be on a novel chemical compound, formulation, or method of use related to drug therapy. To fully understand this patent’s implications, an analysis of its claims and scope is essential, along with an exploration of the landscape it exists within.
Scope and Claims Analysis
Patent Claims Overview
Patent claims define the legal scope of an invention. For CN104822383, the core claims likely outline:
- The chemical structure or composition of a novel pharmaceutical compound.
- Methods of synthesis or preparation.
- Therapeutic applications or specific indications.
- Possible formulations or delivery mechanisms.
The precise wording of these claims determines how broad or narrow the patent protection is.
Key Points of the Claims
-
Chemical Composition or Compound:
The patent probably claims a specific chemical entity with a defined structure, such as a new derivative of an existing drug or a novel molecular scaffold. The claim language might specify certain key functional groups or stereochemistry that distinguish it from prior art.
-
Synthesis Methodology:
If novel, the patent may include claims related to a unique process for preparing the compound, emphasizing steps that improve yield, purity, or efficiency.
-
Therapeutic Use:
Claims might encompass methods of treating particular conditions, such as cancer, inflammation, or infectious diseases, using the compound. Use claims are critical in establishing the scope of patent protection beyond the compound itself.
-
Formulation and Delivery:
Claims could extend to specific pharmaceutical formulations or drug delivery systems that enhance stability, bioavailability, or targeted delivery.
Claim Strategy and Scope
The patent likely employs a combination of broad and narrow claims:
- Broad Claims: Cover the core novel chemical or method, providing extensive protection against similar compounds or synthesis techniques.
- Dependent (Narrow) Claims: Specify particular embodiments, such as specific pharmacological parameters or formulation adjustments.
This layered claim structure ensures the patent’s robustness, guarding against intermediate or modified competitors.
Patent Landscape Analysis
Global Patent Positioning
While CN104822383 pertains specifically to China, the invention’s international relevance raises inquiries into corresponding patents or applications in regions such as the United States, Europe, and Japan. Countries with significant pharmaceutical markets often file corresponding patent families to secure global exclusivity.
Domestic Patent Landscape in China
China’s pharmaceutical patent landscape is rapidly evolving, with increased filings focusing on:
- Chemical entities and derivatives
- Novel drug delivery systems
- Method of use/treatment protocols
CN104822383 fits within this momentum, potentially accompanied by related patents or applications aimed at broadening protection.
Patent Family and Prior Art Considerations
Analyzing the patent family reveals whether the applicant has filed for similar inventions elsewhere, indicating strategic patent coverage. Prior art searches help determine the novelty and inventive step, which are critical for patent validity. For CN104822383, prior art covering similar chemical structures or therapeutic claims would influence its scope and enforceability.
Legal Status and Potential Challenges
The patent’s legal enforceability depends on its current status: granted, pending, or invalidated. Challenges from third parties may include:
- Invalidation proceedings citing prior art
- Oppositions based on lack of novelty or inventive step
- Design-around strategies by competitors
Understanding these risks informs risk management and strategic planning.
Implications of the Patent’s Scope
- Market Exclusivity: The patent provides a monopoly window for the patented compound or method, incentivizing R&D investments.
- Research & Development: The patent’s claims can guide follow-up innovation or derivative works.
- Licensing & Collaboration: Broad claims facilitate licensing opportunities but may also attract litigation if challenged.
Strategic Considerations
- Beyond China: Companies should explore corresponding patent applications in other jurisdictions to maximize global exclusivity.
- Patent Maintenance: Ongoing patent maintenance fees and legal challenges can impact longevity.
- Patent Litigation and Litigation Risks: Broad claims can be protective but also invite patent disputes, requiring vigilant IP enforcement strategies.
Conclusion
Patent CN104822383 offers substantial scope concerning a novel pharmaceutical composition or method of use, with deliberate claim breadth designed to secure exclusive rights in the Chinese market. Its strategic positioning within the evolving Chinese pharmaceutical patent landscape indicates its significance for companies aiming to commercialize new therapies. A thorough understanding of its claims and landscape is vital for steering R&D, licensing, and legal strategies in this sector.
Key Takeaways
- CN104822383’s claims likely cover specific chemical entities, their synthesis methods, and therapeutic applications, making it a robust protective instrument.
- Its scope influences market exclusivity, potential licensing deals, and research directions within China and potentially abroad.
- Continuous monitoring of legal status and associated patent family filings is crucial for maintaining strategic advantage.
- Broader patent strategies should include filing in other jurisdictions to maximize global patent protection.
- Vigilance against patent challenges and vigilant enforcement are necessary to uphold the patent’s value and commercial benefits.
FAQs
1. What is the main innovation claimed by CN104822383?
The patent primarily claims a novel chemical compound with specific structural features, along with methods of synthesis and therapeutic use, tailored to treat particular medical conditions.
2. How broad are the claims in CN104822383?
The claims are designed to balance broad coverage of the core compound and therapeutic applications with narrower claims to specific embodiments, enhancing legal robustness.
3. Can similar patents be filed in other countries?
Yes, companies often file corresponding patent applications internationally through mechanisms like the Patent Cooperation Treaty (PCT) to secure global protection.
4. How does CN104822383 fit into the Chinese pharmaceutical patent landscape?
It aligns with China's increasing focus on chemical and method of use patents, contributing to the growing body of protected pharmaceutical inventions within the country.
5. What are the risks associated with patent challenges?
Potential invalidation, opposition, or design-around strategies by competitors pose risks to patent enforceability, emphasizing the need for vigilant IP management.
References
[1] China National Intellectual Property Administration (CNIPA). Patent Publication CN104822383.
[2] WIPO Patent Cooperation Treaty (PCT) application data.
[3] Chinese pharmaceutical patent landscape reports (2022).
